IP Library Granted Patent US 11,878,964
Granted Patent B2
US 11,878,964 · App. 17/238,525 · Granted Jan 23, 2024

Compositions comprising an urolithin compound

Inventors: Penelope Andreux (Eclepens, CH); Christopher L. Rinsch (Morges, CH); William Blanco-Bose (La Croix, CH)
Assignee: Amazentis SA
C07D311/80A23C9/1307A23L2/52A23L2/66A23L33/19A61K9/0056A61K9/0095A61K9/06A61K9/08A61K9/146A61K31/03A61K31/366A61K38/01A61K38/018A61K38/1709A61K47/42A61P21/00A61P25/00A23L33/105A23L33/40A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,878,964
App. No.
17/238,525
Granted
Jan 23, 2024
Kind
B2
Abstract

The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition. The invention also provides kits comprising urolithin and protein.

Claims (21)

1. A method of improving physical performance, comprising administering to a subject in need thereof an effective amount of a composition comprising a urolithin and a source of protein; wherein the physical performance is walking or running.

2. The method of claim 1 , wherein the subject's performance in the six-minute walk test (MWT) is improved.

3. The method of claim 1 , wherein the subject's time to walk a certain distance (gait speed) is improved.

4. The method of claim 1 , wherein the subject's time to run a certain distance (running speed) is improved.

5. The method of claim 1 , wherein the subject's running economy is improved.

6. The method of claim 1 , wherein the subject's International Physical Activity Questionnaire (IPAQ) score is improved.

7. The method of claim 1 , wherein the subject's number of chair-stands in a certain time is increased.

8. A method of improving muscle function, comprising administering to a subject in need thereof an effective amount of a composition comprising a urolithin and a source of protein; wherein the muscle function is muscle endurance.

9. The method of claim 8 , wherein the subject's muscular contraction strength is increased.

10. The method of claim 8 , wherein the subject's amplitude of muscle contracting is increased.

11. The method of claim 8 , wherein subject's muscle reaction time between stimulation and contraction is shortened.

12. The method of claim 8 , wherein the subject's upper body and/or lower body muscle endurance is improved.

13. The method of claim 12 , wherein the subject's hand grip strength is improved.

14. The method of claim 8 , wherein the subject's skeletal muscle respiratory capacity is increased.

15. The method of claim 14 , wherein the subject's maximal oxygen consumption (VO 2 max ) is increased.

16. The method of claim 8 , wherein the subject's muscle mass is increased.

17. The method of claim 8 , wherein the subject's muscle stem cell regenerative ability is improved.

18. A method of improving physical performance, comprising administering to a subject in need thereof an effective amount of a composition comprising urolithin A and a source of protein.

19. The method of claim 18 , wherein the physical performance is walking or running.

20. A method of improving muscle function, comprising administering to a subject in need thereof an effective amount of a composition comprising urolithin A and a source of protein.

21. The method of claim 20 , wherein the muscle function is muscle endurance.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ANDREUX, PENELOPE; RINSCH, CHRISTOPHER; BLANCO-BOSE, WILLIAM
To: AMAZENTIS SA
Reel/Frame 056119/0241 →
Priority Claims (1)
GB 1515391 · Aug 28, 2015 · national
Continuity (3)
Continuation 16589890 · Oct 1, 2019
Continuation 15757296
Related Publication 20220073488A1 · Mar 10, 2022
Cited By (4)
US 12,297,182 US 12,544,358 US 12,576,064 US 12,576,065